BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 31361517)

  • 21. Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an hiv outbreak: A qualitative study.
    Smith M; Elliott L; Hutchinson SJ; Metcalfe R; Flowers P; McAuley A
    Int J Drug Policy; 2021 Feb; 88():103033. PubMed ID: 33249313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient and Provider Perspectives on a Novel, Low-Threshold HIV PrEP Program for People Who Inject Drugs Experiencing Homelessness.
    Bazzi AR; Shaw LC; Biello KB; Vahey S; Brody JK
    J Gen Intern Med; 2023 Mar; 38(4):913-921. PubMed ID: 35614171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PrEP Care Continuum Engagement Among Persons Who Inject Drugs: Rural and Urban Differences in Stigma and Social Infrastructure.
    Walters SM; Frank D; Van Ham B; Jaiswal J; Muncan B; Earnshaw V; Schneider J; Friedman SR; Ompad DC
    AIDS Behav; 2022 Apr; 26(4):1308-1320. PubMed ID: 34626265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Support Your Client at the Space That They're in": HIV Pre-Exposure Prophylaxis (PrEP) Prescribers' Perspectives on PrEP-Related Risk Compensation.
    Calabrese SK; Magnus M; Mayer KH; Krakower DS; Eldahan AI; Hawkins LAG; Underhill K; Hansen NB; Kershaw TS; Betancourt JR; Dovidio JF
    AIDS Patient Care STDS; 2017 Apr; 31(4):196-204. PubMed ID: 28414261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expansion of Preexposure Prophylaxis Capacity in Response to an HIV Outbreak Among People Who Inject Drugs-Cabell County, West Virginia, 2019.
    Furukawa NW; Weimer M; Willenburg KS; Kilkenny ME; Atkins AD; Paul McClung R; Hansen Z; Napier K; Handanagic S; Carnes NA; Kemp Rinderle J; Neblett-Fanfair R; Oster AM; Smith DK
    Public Health Rep; 2022; 137(1):25-31. PubMed ID: 33646890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-Exposure Prophylaxis (PrEP) for Safer Conception Among Serodifferent Couples: Findings from Healthcare Providers Serving Patients with HIV in Seven US Cities.
    Finocchario-Kessler S; Champassak S; Hoyt MJ; Short W; Chakraborty R; Weber S; Levison J; Phillips J; Storm D; Anderson J
    AIDS Patient Care STDS; 2016 Mar; 30(3):125-33. PubMed ID: 26824425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review.
    Mayer KH; Agwu A; Malebranche D
    Adv Ther; 2020 May; 37(5):1778-1811. PubMed ID: 32232664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland.
    Sherman SG; Schneider KE; Park JN; Allen ST; Hunt D; Chaulk CP; Weir BW
    Drug Alcohol Depend; 2019 Feb; 195():148-155. PubMed ID: 30639794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review.
    Mistler CB; Copenhaver MM; Shrestha R
    AIDS Behav; 2021 May; 25(5):1490-1506. PubMed ID: 32749627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Provider Implicit Bias in Prescribing HIV Pre-exposure Prophylaxis (PrEP) to People Who Inject Drugs.
    Dubov A; Krakower DS; Rockwood N; Montgomery S; Shoptaw S
    J Gen Intern Med; 2023 Oct; 38(13):2928-2935. PubMed ID: 36964426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016-2018.
    Walters SM; Kral AH; Simpson KA; Wenger L; Bluthenthal RN
    Subst Use Misuse; 2020; 55(14):2409-2419. PubMed ID: 32962490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health Care Provider Perspectives on Pre-exposure Prophylaxis: A Qualitative Study.
    Przybyla S; LaValley S; St Vil N
    J Assoc Nurses AIDS Care; 2019; 30(6):630-638. PubMed ID: 30958406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Exploration of Factors Impacting Preexposure Prophylaxis Eligibility and Access Among Syringe Exchange Users.
    Roth AM; Aumaier BL; Felsher MA; Welles SL; Martinez-Donate AP; Chavis M; Van Der Pol B
    Sex Transm Dis; 2018 Apr; 45(4):217-221. PubMed ID: 29465703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida.
    Jo Y; Bartholomew TS; Doblecki-Lewis S; Rodriguez A; Forrest DW; Tomita-Barber J; Oves J; Tookes HE
    PLoS One; 2020; 15(4):e0231424. PubMed ID: 32298320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perspectives on biomedical HIV prevention options among women who inject drugs in Kenya.
    Bazzi AR; Yotebieng KA; Agot K; Rota G; Syvertsen JL
    AIDS Care; 2018 Mar; 30(3):343-346. PubMed ID: 28780885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experiences and challenges of pre-exposure prophylaxis initiation and retention among high-risk populations: qualitative insights among service providers in Thailand.
    Rayanakorn A; Chautrakarn S; Intawong K; Chariyalertsak C; Khemngern P; Olson D; Chariyalertsak S
    Front Public Health; 2024; 12():1366754. PubMed ID: 38813431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC.
    Kuo I; Olsen H; Patrick R; Phillips G; Magnus M; Opoku J; Rawls A; Peterson J; Hamilton F; Kharfen M; Greenberg A
    Drug Alcohol Depend; 2016 Jul; 164():8-13. PubMed ID: 27177804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study protocol for an efficacy trial of the "PrEP for Health" intervention to increase HIV PrEP use among people who inject drugs.
    Bazzi AR; Bordeu M; Baumgartner K; Sproesser DM; Bositis CM; Krakower DS; Mimiaga MJ; Biello KB
    BMC Public Health; 2023 Mar; 23(1):513. PubMed ID: 36932369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors Affecting Pre-Exposure Prophylaxis Implementation for Women in the United States: A Systematic Review.
    Bradley E; Forsberg K; Betts JE; DeLuca JB; Kamitani E; Porter SE; Sipe TA; Hoover KW
    J Womens Health (Larchmt); 2019 Sep; 28(9):1272-1285. PubMed ID: 31180253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knowledge, Practices, and Barriers to HIV Preexposure Prophylaxis Prescribing Among Washington State Medical Providers.
    Wood BR; McMahan VM; Naismith K; Stockton JB; Delaney LA; Stekler JD
    Sex Transm Dis; 2018 Jul; 45(7):452-458. PubMed ID: 29465664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.